42,500 performance shares go to Benjamin Stone at First Tracks (TRAX), tied to share-price targets.
Alpha Vantage · Stock Titan · · AI-summarised by FinFlash
First Tracks Biotherapeutics (TRAX) has granted Chief Business Officer Benjamin Stone 42,500 performance stock units (PSUs) on November 1, 2026. These PSUs, which convert to common shares upon settlement for no consideration, vest based on the achievement of specific share-price metrics and Stone's continued service.
Understand the context
Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.